Cas:60104-30-5 Orazamide manufacturer & supplier

Chemical Name:Orazamide

CAS.NO:60104-30-5

Synonyms:4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, compd. with 5-amino-1H-imidazole-4-carboxamide (1:1);2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid – 4-amino-1H-imidazole-5-carboxamide (1:1);5-aminoIMIDAZOLE-4-carboxamide orotate;Orazamide dihydrate;Orazamid-2-wasser;4-Amino-5-imidazolecarboxamide orotate dihydrate;EINECS 219-923-7;4-Amino-5-imidazolecarboxamide orotate;5-Aminoimidazole-4-carboxamide orotate dihydrate;Aica orotate dihydrate;2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid – 5-amino-1H-imidazole-4-carboxamide (1:1);Aicamin dihydrate;Aicorat dihydrate

Molecular Formula:C₉H₁₀N₆O₅

Molecular Weight:282.213

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:200.81000

Exact Mass:282.071259

LogP:

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 4-Pyrimidinecarboxylic acid, 1,2,3,6-tetrahydro-2,6-dioxo-, compd. with 5-amino-1H-imidazole-4-carboxamide (1:1) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Aicorat dihydrate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid – 4-amino-1H-imidazole-5-carboxamide (1:1) Use and application,2,6-Dioxo-1,2,3,6-tetrahydro-4-pyrimidinecarboxylic acid – 5-amino-1H-imidazole-4-carboxamide (1:1) technical grade,usp/ep/jp grade.

Related News: Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations. Orazamide manufacturer With the death toll surging past 300 and 14,300 cases confirmed, authorities across the country have activated the highest public health emergency response, stepping up screening of arrivals from Wuhan. Orazamide supplier This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. Orazamide vendor With the death toll surging past 300 and 14,300 cases confirmed, authorities across the country have activated the highest public health emergency response, stepping up screening of arrivals from Wuhan. Orazamide factory Beta Bionics is committed to obtaining regulatory approval and commercializing all three iLet configurations.